Sumitomo Dainippon Pharma Co., Ltd. manufactures and sells pharmaceuticals, food ingredients and additives, veterinary medicines, diagnostics, and others. The company offers pharmaceutical products, such as therapeutic agents for Parkinson's disease, depression, type 2 diabetes, systemic fungal infection, pruritus, chronic obstructive pulmonary disease, angina pectoris, and arrhythmia. It also provides atypical antipsychotic, antiepileptic, carbapenem antibiotic, and gastroprokine products; and Anderson-Fabry and Serotonin-agonist antianxiety drugs. In addition, the company offers food ingredients and additives, such as polysaccharides, and seasonings, such as soups or bouillons; and chemical product materials consisting of pharmaceutical excipients, personal care products, coatings and industrial materials, and electronic materials. Further, it provides veterinary medicines for companion animals, primarily dogs and cats; and cattle, swine, poultry, horses, and aquacultured fish. Additionally, the company provides point-of-care testing diagnostic products for infectious diseases comprising influenza, streptococcus, etc., as well as acute myocardial infarction; diagnostics to measure bone and calcium metabolism markers, and drug concentration levels in the blood; high sensitivity products combining small immunofluorescence analyzers and special reagents; and authorized generic pharmaceuticals. Sumitomo Dainippon Pharma Co., Ltd. has partnerships with Healios K.K.; Keio University; RIKEN; the Center for iPS Cell Research and Application (CiRA); Kyoto University; and Aikomi, Ltd., as well as a joint development agreement with SanBio, Inc. The company was formerly known as Dainippon Sumitomo Pharma Co., Ltd. and changed its name to Sumitomo Dainippon Pharma Co., Ltd. in June 2014. Sumitomo Dainippon Pharma Co., Ltd. was founded in 1897 and is headquartered in Osaka, Japan. Sumitomo Dainippon Pharma Co., Ltd. is a subsidiary of Sumitomo Chemical Company, Limited.
Industry, Sector and Symbol
Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone81 6 6203 5321
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
Employees6,140
Next Earnings DateN/A
OptionableNot Optionable
Eisai (OTCMKTS:DNPUF) Frequently Asked Questions
What is Eisai's stock symbol?
Eisai trades on the OTCMKTS under the ticker symbol "DNPUF."
What is the consensus analysts' recommendation for Eisai?
1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Eisai in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Eisai.
Has Eisai been receiving favorable news coverage?
Media headlines about DNPUF stock have been trending somewhat positive recently, InfoTrie Sentiment reports. The research group identifies negative and positive news coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Eisai earned a coverage optimism score of 2.0 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the next few days. View News Stories for Eisai.
Who are some of Eisai's key competitors?
Some companies that are related to Eisai include 1933 Industries (TGIF), Abacus Health Products (ABAHF), Acreage (ACRGF), Alliance Growers (ACG), Applied Biosciences (APPB), Ayr Strategies (AYRSF), Biome Grow (BIO), Blueberries Medical (BBM), Canbiola (CANB), Cannabis Science (CBIS), Cannara Biotech (LOVE), Cansortium (CNTMF), Charlotte's Web (CWBHF), Choom (CHOOF) and Cipher Pharmaceuticals (CPHRF).
Who are Eisai's key executives?
Eisai's management team includes the folowing people:
- Mr. Hiroshi Nomura, CEO, Pres & Representative Director (Age 62)
- Hisayoshi Kashima, Sr. Director & Corp. Controller
- Mr. Kazuhiro Takada, Exec. Officer of Corp. Governance, Legal Affairs & Intellectual Property
- Ms. Atsuko Higuchi, Exec. Officer of Corp. Communications & HR
- Mr. Hitoshi Odagiri, Exec. VP, Exec. Director of Sales & Mktg. Div., Head of Japan Bus. Unit and Director
How do I buy shares of Eisai?
Shares of DNPUF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Eisai's stock price today?
One share of DNPUF stock can currently be purchased for approximately $16.90.
What is Eisai's official website?
How can I contact Eisai?
The company can be reached via phone at 81 6 6203 5321.
MarketBeat Community Rating for Eisai (OTCMKTS DNPUF)
MarketBeat's community ratings are surveys of what our community members think about Eisai and other stocks. Vote "Outperform" if you believe DNPUF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe DNPUF will underperform the S&P 500 over the long term. You may vote once every thirty days.
